Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Aspirin or heparin or both in the treatment of recurrent spontaneous abortion in women with antiphospholipid antibody syndrome: a meta-analysis of randomized controlled trials

Published:2018-01-10 Issue:8 Volume:32 Page:1299-1311
ISSN:1476-7058
Container-title:The Journal of Maternal-Fetal & Neonatal Medicine
language:en
Short-container-title:The Journal of Maternal-Fetal & Neonatal Medicine

Author:

Lu Chang¹,Liu Yong¹,Jiang Hai-Li²

Affiliation:

1. Department of Gynecology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China;

2. Department of Obstetrics, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China

Publisher

Informa UK Limited

Subject

Obstetrics and Gynecology,Pediatrics, Perinatology and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/14767058.2017.1404979

Reference52 articles.

1. Establishment of a standardized immunological diagnostic procedure in RM patients

2. Evidence-based investigations and treatments of recurrent pregnancy loss

3. Epidemiology and the medical causes of miscarriage

4. Obstetric antiphospholipid syndrome: A recent classification for an old defined disorder

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical aspects of antiphospholipid syndrome;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Low-molecular-weight heparin and preeclampsia — does the sword cut both ways? Three case reports and review of literature;World Journal of Clinical Cases;2024-03-26

3. Reproductive factors and subsequent pregnancy outcomes in patients with prior pregnancy loss;BMC Pregnancy and Childbirth;2024-03-25

4. The role of acetylsalicylic acid in the prevention of pre-eclampsia, fetal growth restriction, and preterm birth;Deutsches Ärzteblatt international;2023-09-15

5. How to reverse severe midtrimester oligohydramnios secondary to non-criteria obstetricantiphospholipid syndrome: a case report;2023-09-07